| Literature DB >> 33752856 |
Carlos L Manrique-Caballero1, Gaspar Del Rio-Pertuz2, Hernando Gomez3.
Abstract
Sepsis-associated acute kidney injury (S-AKI) is a common and life-threatening complication in hospitalized and critically ill patients. It is characterized by rapid deterioration of renal function associated with sepsis. The pathophysiology of S-AKI remains incompletely understood, so most therapies remain reactive and nonspecific. Possible pathogenic mechanisms to explain S-AKI include microcirculatory dysfunction, a dysregulated inflammatory response, and cellular metabolic reprogramming. In addition, several biomarkers have been developed in an attempt to improve diagnostic sensitivity and specificity of S-AKI. This article discusses the current understanding of S-AKI, recent advances in pathophysiology and biomarker development, and current preventive and therapeutic approaches.Entities:
Keywords: AKI; Biomarkers; Inflammation; Metabolic reprogramming; Microcirculation; Sepsis
Mesh:
Substances:
Year: 2021 PMID: 33752856 PMCID: PMC7995616 DOI: 10.1016/j.ccc.2020.11.010
Source DB: PubMed Journal: Crit Care Clin ISSN: 0749-0704 Impact factor: 3.598